Helen Reeves
Helen is an academic hepatologist, looking after patients with primary liver cancer. Her long term goal is to improve outcomes for these patients, in part by developing tools to detect their cancers earlier, but also by identifying novel therapeutic candidates to take forward into clinical use, alongside the biomarkers needed to implement them. Helen made a significant contribution to our first study which evaluated the use of the "TAPS" assay for HCC early detection led by Chunxiao Song.
